Thursday - March 28, 2024
SEC Obtains Penalty, Bar From Founder, CEO of Massachusetts-based Pharma Company
August 22, 2017
WASHINGTON, Aug. 22 -- The Securities and Exchange Commission issued the following litigation release:

The Securities and Exchange Commission has obtained a final judgment against the founder and CEO of BioChemics Inc., who was charged with making false statements about collaborations with major pharmaceutical companies and the status and results of drug trials of the company's main product.

The final judgment, entered by consent on August 18, 2017 by the Honorable Mark . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products